Increasing awareness highlights a new type of therapies known as GLP-1 receptor agonists. Specifically , Tirzepatide , Semaglutide Injection, and Retatrutid are representing the most illustrations of this field. Such agents work by modulating the body’s natural GLP-1 substance , contributing to